These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 25280114)

  • 21. Use of hydroxyprogesterone caproate to prevent preterm labour in uterine didelphys: a case report.
    Ng KS; Ng BK; Lim PS; Shafiee MN; Abdul Karim AK; Omar MH
    Horm Mol Biol Clin Investig; 2016 Sep; 27(3):89-91. PubMed ID: 26684353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of progestogens for the prevention of premature birth.
    Schindler AE
    J Steroid Biochem Mol Biol; 2005 Dec; 97(5):435-8. PubMed ID: 16198556
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimal routes of administration, vehicles and timing of progesterone treatment for inhibition of delivery during pregnancy.
    Fang D; Moreno M; Garfield RE; Kuon R; Xia H
    Eur J Obstet Gynecol Reprod Biol; 2017 Sep; 216():164-168. PubMed ID: 28777967
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of 17-alpha hydroxyprogesterone caproate on the risk of gestational diabetes in singleton or twin pregnancies.
    Gyamfi C; Horton AL; Momirova V; Rouse DJ; Caritis SN; Peaceman AM; Sciscione A; Meis PJ; Spong CY; Dombrowski M; Sibai B; Varner MW; Iams JD; Mercer BM; Carpenter MW; Lo J; Ramin SM; O'Sullivan MJ; Miodovnik M; Conway D;
    Am J Obstet Gynecol; 2009 Oct; 201(4):392.e1-5. PubMed ID: 19716543
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The end is where we start from: withdrawal of 17-alpha hydroxyprogesterone caproate to prevent recurrent preterm birth.
    Nelson DB; Herrera CL; McIntire DD; Cunningham FG
    Am J Obstet Gynecol; 2024 Jan; 230(1):1-9. PubMed ID: 37798189
    [No Abstract]   [Full Text] [Related]  

  • 26. 17α-hydroxyprogesterone caproate for the prevention of adverse neonatal outcome in multiple pregnancies: a randomized controlled trial.
    O'Brien JM
    Obstet Gynecol; 2012 Feb; 119(2 Pt 1):384-5; author reply 385-6. PubMed ID: 22270303
    [No Abstract]   [Full Text] [Related]  

  • 27. Regarding 'Gestational age at initiation of 17-alpha hydroxyprogesterone caproate and recurrent preterm birth'.
    Deng Z; Lu D
    Eur J Obstet Gynecol Reprod Biol; 2022 Mar; 270():246. PubMed ID: 35151530
    [No Abstract]   [Full Text] [Related]  

  • 28. 17-alpha-hydroprogesterone caproate and cervical changes.
    Facchinetti F
    Am J Obstet Gynecol; 2010 Sep; 203(3):e9; author reply e10. PubMed ID: 20537309
    [No Abstract]   [Full Text] [Related]  

  • 29. Cerclage, progesterone and α-hydroxyprogeterone caproate treatment in women at risk for preterm delivery.
    Haram K; Mortensen JH; Morrison JC
    J Matern Fetal Neonatal Med; 2014 Nov; 27(16):1710-5. PubMed ID: 24678618
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 17-Hydroxyprogesterone caproate in triplet pregnancy: an individual patient data meta-analysis.
    Combs CA; Schuit E; Caritis SN; Lim AC; Garite TJ; Maurel K; Rouse D; Thom E; Tita AT; Mol B;
    BJOG; 2016 Apr; 123(5):682-90. PubMed ID: 26663620
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Progestogens for Maintenance Tocolysis in Women With a Short Cervix: A Randomized Controlled Trial.
    Facchinetti F; Vergani P; Di Tommaso M; Marozio L; Acaia B; Vicini R; Pignatti L; Locatelli A; Spitaleri M; Benedetto C; Zaina B; DʼAmico R
    Obstet Gynecol; 2017 Jul; 130(1):64-70. PubMed ID: 28594783
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deus ex Makena?
    Silver RM; Cunningham FG
    Obstet Gynecol; 2011 Jun; 117(6):1263-1265. PubMed ID: 21471852
    [No Abstract]   [Full Text] [Related]  

  • 33. Vaginal Progesterone Is Associated with Intrahepatic Cholestasis of Pregnancy.
    Tsur A; Leonard SA; Kan P; Datoc IA; Girsen AI; Shaw GM; Stevenson DK; El-Sayed YY; Druzin ML; Blumenfeld YJ
    Am J Perinatol; 2023 Aug; 40(11):1158-1162. PubMed ID: 37100422
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 17 alpha-hydroxyprogesterone caproate does not prolong pregnancy or reduce the rate of preterm birth in women at high risk for preterm delivery and a short cervix: a randomized controlled trial.
    Winer N; Bretelle F; Senat MV; Bohec C; Deruelle P; Perrotin F; Connan L; Vayssière C; Langer B; Capelle M; Azimi S; Porcher R; Rozenberg P;
    Am J Obstet Gynecol; 2015 Apr; 212(4):485.e1-485.e10. PubMed ID: 25448515
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reducing Barriers to 17-Hydroxprogestrone Caproate (17P) Injections to Prevent Recurrent Preterm Birth in Mississippi.
    Bofill JA; Collier CH; Pearson M; Shwayder JM; Morrison JC
    J Miss State Med Assoc; 2016 Nov; 57(11):350-351. PubMed ID: 30281234
    [No Abstract]   [Full Text] [Related]  

  • 36. The effect of 17α-hydroxyprogesterone caproate on preterm birth in women with an ultrasound-indicated cerclage.
    Rafael TJ; Mackeen AD; Berghella V
    Am J Perinatol; 2011 May; 28(5):389-94. PubMed ID: 21380984
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of 17α-hydroxyprogesterone caproate in prevention of preterm delivery.
    Saghafi N; Khadem N; Mohajeri T; Shakeri MT
    J Obstet Gynaecol Res; 2011 Oct; 37(10):1342-5. PubMed ID: 21564406
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does progesterone treatment influence risk factors for recurrent preterm delivery?
    Meis PJ; Klebanoff M; Dombrowski MP; Sibai BM; Leindecker S; Moawad AH; Northen A; Iams JD; Varner MW; Caritis SN; O'Sullivan MJ; Miodovnik M; Leveno KJ; Conway D; Wapner RJ; Carpenter M; Mercer B; Ramin SM; Thorp JM; Peaceman AM; Gabbe S
    Obstet Gynecol; 2005 Sep; 106(3):557-61. PubMed ID: 16135587
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictors of response to 17-alpha hydroxyprogesterone caproate for prevention of recurrent spontaneous preterm birth.
    Manuck TA; Esplin MS; Biggio J; Bukowski R; Parry S; Zhang H; Huang H; Varner MW; Andrews W; Saade G; Sadovsky Y; Reddy UM; Ilekis J;
    Am J Obstet Gynecol; 2016 Mar; 214(3):376.e1-8. PubMed ID: 26692181
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between 17-hydroxyprogesterone caproate concentrations and gestational age at delivery in twin gestation.
    Caritis SN; Simhan HN; Zhao Y; Rouse DJ; Peaceman AM; Sciscione A; Spong CY; Varner MW; Malone FD; Iams JD; Mercer BM; Thorp JM; Sorokin Y; Carpenter M; Lo J; Ramin SM; Harper M;
    Am J Obstet Gynecol; 2012 Nov; 207(5):396.e1-8. PubMed ID: 22959763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.